FOSTIMON

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Finland, France, Ireland, Israel, Malta, Netherlands, Poland, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug FOSTIMON contains one active pharmaceutical ingredient (API):

1
UNII W9BB98U6HP - UROFOLLITROPIN
 

Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure.

 
Read more about Urofollitropin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 FOSTIMON Powder and solvent for solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G03GA04 Urofollitropin G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 525213050018604, 525213050018704, 525213050018804, 525213050018904, 525213050019004, 525213050019104
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 22.453-1-01-06, 22.455-1-01-06
FI Lääkealan turvallisuus- ja kehittämiskeskus 054768, 415813, 531676, 580901
FR Base de données publique des médicaments 60549797, 61166549, 62712912, 69325035
GB Medicines & Healthcare Products Regulatory Agency 108913, 108921
IL מִשְׂרַד הַבְּרִיאוּת 6065, 6066
MT Medicines Authority AA770/08601
NL Z-Index G-Standaard 15858693
NL Z-Index G-Standaard, PRK 104531, 116319, 121517, 82414
PL Rejestru Produktów Leczniczych 100087044
TN Direction de la Pharmacie et du Médicament 13533011, 13533012
TR İlaç ve Tıbbi Cihaz Kurumu 8680426040013, 8680426040020, 8680426040075, 8680426040082
ZA Health Products Regulatory Authority 42/21.10/0184

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.